FDA Allows First Ibogaine-Based Clinical Study
Topics
Developing
- 863d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 863d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 863d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 863d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
“FDA also allowed a clinical study of a medication based on Ibogaine, which is a psychedelic extracted from an African shrub, and the pharmaceutical company studying it wants to use it to treat alcoholism.”
“the FDA also allowed a clinical study of a medication based on ibogaine, which is a psychedelic extracted from an African shrub, and the pharmaceutical company studying it wants to use it to treat alcoholism.”
“the pharmaceutical company studying it wants to use it to treat alcoholism.”
“The FDA also allowed a clinical study of a medication based on ibogaine, which is a psychedelic extracted from an African shrub. And the pharmaceutical company studying it wants to use it to treat alcoholism.”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade